Femtechinsiderfeed

Polycystic ovary syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a global consensus study published today in The Lancet and presented at the European Congress of Endocrinology in Prague. The new name recognizes that the condition affecting more than 170 million people worldwide is not primarily a gynecological disorder, bu...

Mother Ventures has closed a $10 million Fund I focused exclusively on companies where the mother is the primary consumer – a market the firm says represents 85% of U.S. household spending and more than $2.4 trillion in annual purchasing power across 85 million Americans. The fund has already deployed $4 million into 13 portfolio companies, with 100% serving moms as the…

Baymatob, an Australian medical device company, has received funding from the New South Wales Medical Devices Fund to advance Oli, an AI-powered maternal-fetal health platform designed to provide early warning for serious complications in pregnancy and labor including postpartum hemorrhage, stillbirth, and uterine rupture. The funding was part of a A$7.4 million round awarded...

In recent weeks several new funds have launched or closed that are worth knowing about if you’re building in women’s health, consumer health, or wellness. TechThrive Ventures – $7M Pre-Seed Fund TechThrive Ventures, founded by Navneet Kaur and based in San Francisco, has launched a $7 million inaugural pre-seed fund focused on consumer health, wellness, longevity, and women’s...

Artera, a developer of AI-based prognostic and predictive cancer tests, has received FDA clearance for ArteraAI Breast – a digital pathology-based risk stratification tool for patients with early-stage, hormone receptor-positive (HR+), HER2-negative invasive breast cancer. ArteraAI Breast generates an AI-derived risk score that provides prognostic information on the likelihoo...